{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:24:01Z","timestamp":1783423441339,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01905-5","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:03:42Z","timestamp":1759755822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical outcomes and prognostic factors in patients undergoing radical nephrectomy with lymphadenectomy for pN1 renal cell carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Xianjun","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"1905_CR1","doi-asserted-by":"publisher","first-page":"1062504","DOI":"10.3389\/fpubh.2022.1062504","volume":"10","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang L, Wang S, Xie L. Burden of kidney cancer and attributed risk factors in China from 1990 to 2019. Front Public Health. 2022;10:1062504.","journal-title":"Front Public Health"},{"issue":"4","key":"1905_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00345-016-1886-3","volume":"35","author":"U Capitanio","year":"2017","unstructured":"Capitanio U, Leibovich BC. The rationale and the role of lymph node dissection in renal cell carcinoma. World J Urol. 2017;35(4):497\u2013506.","journal-title":"World J Urol"},{"issue":"4","key":"1905_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fern\u00e1ndez-Pello S, Giles RH, Hofmann F, Hora M, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82(4):399\u2013410.","journal-title":"Eur Urol"},{"issue":"2","key":"1905_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal mass and localized renal cancer: evaluation, management, and Follow-Up: AUA guideline: part I. J Urol. 2021;206(2):199\u2013208.","journal-title":"J Urol"},{"key":"1905_CR5","unstructured":"Azawi NH, Tesfalem H, Mosholt KS, H\u00f8yerup P, Jensen ES, Malchau E, Fode M. Recurrence rates and survival in a Danish cohort with renal cell carcinoma. Dan Med J. 2016;63(4)."},{"issue":"2","key":"1905_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (Oxford England: 1990). 2009;45(2):228\u201347.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"issue":"5","key":"1905_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Gr\u00fcnwald V, Gillessen S, Horwich A. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Annals Oncology: Official J Eur Soc Med Oncol. 2019;30(5):706\u201320.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"10","key":"1905_CR8","doi-asserted-by":"publisher","first-page":"e435431","DOI":"10.1016\/j.urolonc.2023.07.011","volume":"41","author":"I Rakic","year":"2023","unstructured":"Rakic I, Rakic N, Stephens A, Corsi N, Davis M, Tinsley S, Butaney M, Arora S, Sood A, Autorino R, et al. Assessing the impact of lymphovascular invasion on overall survival in surgically treated renal cell carcinoma patients: A nationwide cohort analysis. Urol Oncol. 2023;41(10):e435431\u20139.","journal-title":"Urol Oncol"},{"issue":"10","key":"1905_CR9","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1464-410X.2008.08236.x","volume":"103","author":"J Bedke","year":"2009","unstructured":"Bedke J, Buse S, Pritsch M, Macher-Goeppinger S, Schirmacher P, Haferkamp A, Hohenfellner M. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences. BJU Int. 2009;103(10):1349\u201354.","journal-title":"BJU Int"},{"issue":"1","key":"1905_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","volume":"55","author":"JH Blom","year":"2009","unstructured":"Blom JH, van Poppel H, Mar\u00e9chal JM, Jacqmin D, Schr\u00f6der FH, de Prijck L, Sylvester R. Radical nephrectomy with and without lymph-node dissection: final results of European organization for research and treatment of cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55(1):28\u201334.","journal-title":"Eur Urol"},{"issue":"5","key":"1905_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.urolonc.2020.01.013","volume":"38","author":"G Rosiello","year":"2020","unstructured":"Rosiello G, Palumbo C, Knipper S, Pecoraro A, Luzzago S, Tian Z, Larcher A, Capitanio U, Montorsi F, Shariat SF, et al. Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. Urol Oncol. 2020;38(5):537\u201344.","journal-title":"Urol Oncol"},{"issue":"5","key":"1905_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/bju.14127","volume":"121","author":"B Bhindi","year":"2018","unstructured":"Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, et al. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. BJU Int. 2018;121(5):684\u201398.","journal-title":"BJU Int"},{"issue":"1","key":"1905_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.urolonc.2018.10.004","volume":"37","author":"NJ Farber","year":"2019","unstructured":"Farber NJ, Rivera-N\u00fa\u00f1ez Z, Kim S, Shinder B, Radadia K, Sterling J, Modi PK, Goyal S, Parikh R, Mayer TM, et al. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National cancer database. Urol Oncol. 2019;37(1):26\u201332.","journal-title":"Urol Oncol"},{"issue":"5","key":"1905_CR14","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.juro.2010.12.053","volume":"185","author":"JM Whitson","year":"2011","unstructured":"Whitson JM, Harris CR, Reese AC, Meng MV. Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol. 2011;185(5):1615\u201320.","journal-title":"J Urol"},{"key":"1905_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.urology.2019.04.026","volume":"130","author":"T Kuusk","year":"2019","unstructured":"Kuusk T, Brouwer O, Graafland N, Hendricksen K, Donswijk M, Bex A. Sentinel lymph node biopsy in renal tumors: surgical technique and safety. Urology. 2019;130:186\u201390.","journal-title":"Urology"},{"issue":"3","key":"1905_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10147-011-0241-3","volume":"16","author":"BF Chapin","year":"2011","unstructured":"Chapin BF, Delacroix SE Jr., Wood CG. The role of lymph node dissection in renal cell carcinoma. Int J Clin Oncol. 2011;16(3):186\u201394.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"1905_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2017.09.008","volume":"73","author":"RJ Motzer","year":"2018","unstructured":"Motzer RJ, Ravaud A, Patard JJ, Pandha HS, George DJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, et al. Adjuvant Sunitinib for High-risk renal cell carcinoma after nephrectomy: subgroup analyses and updated overall survival results. Eur Urol. 2018;73(1):62\u20138.","journal-title":"Eur Urol"},{"issue":"8","key":"1905_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2106391","volume":"385","author":"TK Choueiri","year":"2021","unstructured":"Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, et al. Adjuvant pembrolizumab after nephrectomy in Renal-Cell carcinoma. N Engl J Med. 2021;385(8):683\u201394.","journal-title":"N Engl J Med"},{"issue":"3","key":"1905_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.clgc.2023.01.005","volume":"21","author":"FSM Monteiro","year":"2023","unstructured":"Monteiro FSM, Soares A, Rizzo A, Santoni M, Mollica V, Grande E, Massari F. The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis. Clin Genitourin Cancer. 2023;21(3):324\u201333.","journal-title":"Clin Genitourin Cancer"},{"key":"1905_CR20","doi-asserted-by":"publisher","unstructured":"Gu L, Peng C, Li H, Jia T, Chen X, Wang H, Du S, Tang L, Liang Q, Wang B et al. Neoadjuvant therapy in renal cell carcinoma with tumor thrombus: A systematic review and meta-analysis.\u00a0Crit Rev Oncol Hematol.\u00a02024;196.\u00a0https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104316","DOI":"10.1016\/j.critrevonc.2024.104316"},{"issue":"1","key":"1905_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/curroncol30010002","volume":"30","author":"O Zalay","year":"2022","unstructured":"Zalay O, Yan M, Sigurdson S. Adjuvant radiotherapy for upper tract urothelial carcinoma: systematic review and Meta-Analysis. Curr Oncol (Toronto Ont). 2022;30(1):19\u201336.","journal-title":"Curr Oncol (Toronto Ont)"},{"issue":"5","key":"1905_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/MOU.0000000000000312","volume":"26","author":"M Moschini","year":"2016","unstructured":"Moschini M, Dell\u2019Oglio P, Larcher A, Capitanio U. Lymph node dissection for renal cell carcinoma: what are we missing? Curr Opin Urol. 2016;26(5):424\u201331.","journal-title":"Curr Opin Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01905-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T13:03:43Z","timestamp":1759755823000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01905-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1905"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01905-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Fourth Affiliated Hospital of Harbin Medical University, and the study was performed in accordance with the Helsinki II declaration. Informed consent was waived because the research was retrospective and conducted on anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}